4D-150
Gene Therapy Target: VEGF-A, VEGF-B, VEGF-C, PlGF
4D Molecular Therapeutics
Most recent annual filing: 2026-03-18
Pipeline (5 active programs)
4D-175
Gene Therapy Target: complement factor H
4D-710
Gene Therapy Target: CFTR
4D-725
Gene Therapy Target: alpha-1 antitrypsin
Technology platforms
Therapeutic Vector Evolution
Directed evolution platform applied in non-human primate models to generate diverse libraries of ~1 billion synthetic AAV capsid sequences and select customized evolved vectors targeting specific tissues; disease focus includes retina and lung diseases
Biotech Distilled coverage (1)
Articles open on Substack. Some deep dives are subscriber-only.